IGF1 and cancer: The insulin-, the IGF-1-, and the leptin-induced signaling cascades converge on activation of PI3K/AKT-mTOR pathway, which stimulates cancer cell proliferation and survival, the latter being also stimulated by the estrogen-induced CDK4/6.